▶ 調査レポート

定位ガイド下生検器具の世界市場 2020年

• 英文タイトル:Global Stereotactic-guided Biopsy Instrument Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。定位ガイド下生検器具の世界市場 2020年 / Global Stereotactic-guided Biopsy Instrument Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / GIR201109194資料のイメージです。• レポートコード:GIR201109194
• 出版社/出版日:GlobalInfoResearch / 2020年10月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、109ページ
• 納品方法:Eメール
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本書では、定位ガイド下生検器具の世界市場を調査対象にし、定位ガイド下生検器具の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(針ベース生検器具、ローカリゼーションワイヤー、手順トレイ、その他)、用途別分析(乳房生検、肺生検、結腸直腸生検、前立腺生検、その他)、市場予測(2021年~2025年)、販売チャンネル・代理店分析情報などを整理しました。
・市場概要
・メーカー情報:C. R. Bard, Inc. (U.S.)、Olympus Corporation (Japan)、Devicor Medical Products, Inc., (Leica Biosystems) (Germany)、Becton, Dickinson and Company (U.S.)、Cardinal Health, Inc. (U.S.)、Cook Group Incorporated (U.S.)、FUJIFILM Holdings Corporation (Japan)、B. Braun Melsungen AG (Germany)、Argon Medical Devices (U.S.)、Boston Scientific Corporation (U.S.)、INRAD, Inc. (U.S.)、Medtronic plc (Ireland)
・メーカー別販売量、売上、市場シェア
・定位ガイド下生検器具の地域別市場分析
・定位ガイド下生検器具の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・定位ガイド下生検器具のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・定位ガイド下生検器具のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・定位ガイド下生検器具の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・定位ガイド下生検器具の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・定位ガイド下生検器具の種類別市場規模2015-2020:針ベース生検器具、ローカリゼーションワイヤー、手順トレイ、その他
・定位ガイド下生検器具の用途別市場規模2015-2020:乳房生検、肺生検、結腸直腸生検、前立腺生検、その他
・定位ガイド下生検器具の世界市場予測2021-2025:地域別、種類別、用途別
・販売チャンネル・代理店分析
・調査の結果・結論

Market Overview
The global Stereotactic-guided Biopsy Instrument market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Stereotactic-guided Biopsy Instrument market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Stereotactic-guided Biopsy Instrument market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Stereotactic-guided Biopsy Instrument market has been segmented into
Needle-based Biopsy Instruments
Localization Wires
Procedure Trays
Others

By Application, Stereotactic-guided Biopsy Instrument has been segmented into:
Breast Biopsy
Lung Biopsy
Colorectal Biopsy
Prostate Biopsy
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Stereotactic-guided Biopsy Instrument market presented in the report. This section sheds light on the sales growth of different regional and country-level Stereotactic-guided Biopsy Instrument markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Stereotactic-guided Biopsy Instrument market.

The report offers in-depth assessment of the growth and other aspects of the Stereotactic-guided Biopsy Instrument market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Stereotactic-guided Biopsy Instrument Market Share Analysis
Stereotactic-guided Biopsy Instrument competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Stereotactic-guided Biopsy Instrument sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Stereotactic-guided Biopsy Instrument sales, revenue and market share for each player covered in this report.

The major players covered in Stereotactic-guided Biopsy Instrument are:
C. R. Bard, Inc. (U.S.)
Olympus Corporation (Japan)
Devicor Medical Products, Inc., (Leica Biosystems) (Germany)
Becton, Dickinson and Company (U.S.)
Cardinal Health, Inc. (U.S.)
Cook Group Incorporated (U.S.)
FUJIFILM Holdings Corporation (Japan)
B. Braun Melsungen AG (Germany)
Argon Medical Devices (U.S.)
Boston Scientific Corporation (U.S.)
INRAD, Inc. (U.S.)
Medtronic plc (Ireland)

Among other players domestic and global, Stereotactic-guided Biopsy Instrument market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Stereotactic-guided Biopsy Instrument product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Stereotactic-guided Biopsy Instrument, with price, sales, revenue and global market share of Stereotactic-guided Biopsy Instrument in 2018 and 2019.
Chapter 3, the Stereotactic-guided Biopsy Instrument competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Stereotactic-guided Biopsy Instrument breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Stereotactic-guided Biopsy Instrument market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Stereotactic-guided Biopsy Instrument sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Stereotactic-guided Biopsy Instrument Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Stereotactic-guided Biopsy Instrument Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Needle-based Biopsy Instruments
1.2.3 Localization Wires
1.2.4 Procedure Trays
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Stereotactic-guided Biopsy Instrument Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Breast Biopsy
1.3.3 Lung Biopsy
1.3.4 Colorectal Biopsy
1.3.5 Prostate Biopsy
1.3.6 Others
1.4 Overview of Global Stereotactic-guided Biopsy Instrument Market
1.4.1 Global Stereotactic-guided Biopsy Instrument Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 C. R. Bard, Inc. (U.S.)
2.1.1 C. R. Bard, Inc. (U.S.) Details
2.1.2 C. R. Bard, Inc. (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 C. R. Bard, Inc. (U.S.) SWOT Analysis
2.1.4 C. R. Bard, Inc. (U.S.) Product and Services
2.1.5 C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Olympus Corporation (Japan)
2.2.1 Olympus Corporation (Japan) Details
2.2.2 Olympus Corporation (Japan) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Olympus Corporation (Japan) SWOT Analysis
2.2.4 Olympus Corporation (Japan) Product and Services
2.2.5 Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Devicor Medical Products, Inc., (Leica Biosystems) (Germany)
2.3.1 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Details
2.3.2 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) SWOT Analysis
2.3.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Product and Services
2.3.5 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Becton, Dickinson and Company (U.S.)
2.4.1 Becton, Dickinson and Company (U.S.) Details
2.4.2 Becton, Dickinson and Company (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Becton, Dickinson and Company (U.S.) SWOT Analysis
2.4.4 Becton, Dickinson and Company (U.S.) Product and Services
2.4.5 Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Cardinal Health, Inc. (U.S.)
2.5.1 Cardinal Health, Inc. (U.S.) Details
2.5.2 Cardinal Health, Inc. (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Cardinal Health, Inc. (U.S.) SWOT Analysis
2.5.4 Cardinal Health, Inc. (U.S.) Product and Services
2.5.5 Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Cook Group Incorporated (U.S.)
2.6.1 Cook Group Incorporated (U.S.) Details
2.6.2 Cook Group Incorporated (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Cook Group Incorporated (U.S.) SWOT Analysis
2.6.4 Cook Group Incorporated (U.S.) Product and Services
2.6.5 Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 FUJIFILM Holdings Corporation (Japan)
2.7.1 FUJIFILM Holdings Corporation (Japan) Details
2.7.2 FUJIFILM Holdings Corporation (Japan) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 FUJIFILM Holdings Corporation (Japan) SWOT Analysis
2.7.4 FUJIFILM Holdings Corporation (Japan) Product and Services
2.7.5 FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 B. Braun Melsungen AG (Germany)
2.8.1 B. Braun Melsungen AG (Germany) Details
2.8.2 B. Braun Melsungen AG (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 B. Braun Melsungen AG (Germany) SWOT Analysis
2.8.4 B. Braun Melsungen AG (Germany) Product and Services
2.8.5 B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Argon Medical Devices (U.S.)
2.9.1 Argon Medical Devices (U.S.) Details
2.9.2 Argon Medical Devices (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Argon Medical Devices (U.S.) SWOT Analysis
2.9.4 Argon Medical Devices (U.S.) Product and Services
2.9.5 Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Boston Scientific Corporation (U.S.)
2.10.1 Boston Scientific Corporation (U.S.) Details
2.10.2 Boston Scientific Corporation (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Boston Scientific Corporation (U.S.) SWOT Analysis
2.10.4 Boston Scientific Corporation (U.S.) Product and Services
2.10.5 Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 INRAD, Inc. (U.S.)
2.11.1 INRAD, Inc. (U.S.) Details
2.11.2 INRAD, Inc. (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 INRAD, Inc. (U.S.) SWOT Analysis
2.11.4 INRAD, Inc. (U.S.) Product and Services
2.11.5 INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Medtronic plc (Ireland)
2.12.1 Medtronic plc (Ireland) Details
2.12.2 Medtronic plc (Ireland) Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Medtronic plc (Ireland) SWOT Analysis
2.12.4 Medtronic plc (Ireland) Product and Services
2.12.5 Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Stereotactic-guided Biopsy Instrument Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Stereotactic-guided Biopsy Instrument Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Stereotactic-guided Biopsy Instrument Manufacturer Market Share in 2019
3.3.2 Top 6 Stereotactic-guided Biopsy Instrument Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Stereotactic-guided Biopsy Instrument Sales, Revenue and Market Share by Regions
4.1.1 Global Stereotactic-guided Biopsy Instrument Sales and Market Share by Regions (2015-2020)
4.1.2 Global Stereotactic-guided Biopsy Instrument Revenue and Market Share by Regions (2015-2020)
4.2 North America Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
4.3 Europe Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
4.5 South America Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Stereotactic-guided Biopsy Instrument Sales, Revenue and Market Share by Country
5.1.1 North America Stereotactic-guided Biopsy Instrument Sales and Market Share by Country (2015-2020)
5.1.2 North America Stereotactic-guided Biopsy Instrument Revenue and Market Share by Country (2015-2020)
5.2 United States Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
5.3 Canada Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
5.4 Mexico Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Stereotactic-guided Biopsy Instrument Sales, Revenue and Market Share by Country
6.1.1 Europe Stereotactic-guided Biopsy Instrument Sales and Market Share by Country (2015-2020)
6.1.2 Europe Stereotactic-guided Biopsy Instrument Revenue and Market Share by Country (2015-2020)
6.2 Germany Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
6.3 UK Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
6.4 France Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
6.5 Russia Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
6.6 Italy Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Stereotactic-guided Biopsy Instrument Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Stereotactic-guided Biopsy Instrument Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Stereotactic-guided Biopsy Instrument Revenue and Market Share by Regions (2015-2020)
7.2 China Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
7.3 Japan Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
7.4 Korea Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
7.5 India Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
7.7 Australia Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Stereotactic-guided Biopsy Instrument Sales, Revenue and Market Share by Country
8.1.1 South America Stereotactic-guided Biopsy Instrument Sales and Market Share by Country (2015-2020)
8.1.2 South America Stereotactic-guided Biopsy Instrument Revenue and Market Share by Country (2015-2020)
8.2 Brazil Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
8.3 Argentina Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Stereotactic-guided Biopsy Instrument Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Stereotactic-guided Biopsy Instrument Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Stereotactic-guided Biopsy Instrument Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
9.3 Turkey Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
9.4 Egypt Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
9.5 South Africa Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Stereotactic-guided Biopsy Instrument Sales and Market Share by Type (2015-2020)
10.2 Global Stereotactic-guided Biopsy Instrument Revenue and Market Share by Type (2015-2020)
10.3 Global Stereotactic-guided Biopsy Instrument Price by Type (2015-2020)
11 Global Stereotactic-guided Biopsy Instrument Market Segment by Application
11.1 Global Stereotactic-guided Biopsy Instrument Sales Market Share by Application (2015-2020)
11.2 Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Application (2015-2020)
11.3 Global Stereotactic-guided Biopsy Instrument Price by Application (2015-2020)
12 Market Forecast
12.1 Global Stereotactic-guided Biopsy Instrument Sales, Revenue and Growth Rate (2021-2025)
12.2 Stereotactic-guided Biopsy Instrument Market Forecast by Regions (2021-2025)
12.2.1 North America Stereotactic-guided Biopsy Instrument Market Forecast (2021-2025)
12.2.2 Europe Stereotactic-guided Biopsy Instrument Market Forecast (2021-2025)
12.2.3 Asia-Pacific Stereotactic-guided Biopsy Instrument Market Forecast (2021-2025)
12.2.4 South America Stereotactic-guided Biopsy Instrument Market Forecast (2021-2025)
12.2.5 Middle East & Africa Stereotactic-guided Biopsy Instrument Market Forecast (2021-2025)
12.3 Stereotactic-guided Biopsy Instrument Market Forecast by Type (2021-2025)
12.3.1 Global Stereotactic-guided Biopsy Instrument Sales Forecast by Type (2021-2025)
12.3.2 Global Stereotactic-guided Biopsy Instrument Market Share Forecast by Type (2021-2025)
12.4 Stereotactic-guided Biopsy Instrument Market Forecast by Application (2021-2025)
12.4.1 Global Stereotactic-guided Biopsy Instrument Sales Forecast by Application (2021-2025)
12.4.2 Global Stereotactic-guided Biopsy Instrument Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Stereotactic-guided Biopsy Instrument Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Stereotactic-guided Biopsy Instrument by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Stereotactic-guided Biopsy Instrument Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. C. R. Bard, Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table 8. C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Major Business
Table 9. C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Total Revenue (USD Million) (2018-2019)
Table 10. C. R. Bard, Inc. (U.S.) SWOT Analysis
Table 11. C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product and Services
Table 12. C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Olympus Corporation (Japan) Basic Information, Manufacturing Base and Competitors
Table 14. Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Major Business
Table 15. Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Total Revenue (USD Million) (2018-2019)
Table 16. Olympus Corporation (Japan) SWOT Analysis
Table 17. Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Product and Services
Table 18. Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Basic Information, Manufacturing Base and Competitors
Table 20. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Major Business
Table 21. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Total Revenue (USD Million) (2018-2019)
Table 22. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) SWOT Analysis
Table 23. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Product and Services
Table 24. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Becton, Dickinson and Company (U.S.) Basic Information, Manufacturing Base and Competitors
Table 26. Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Major Business
Table 27. Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Total Revenue (USD Million) (2018-2019)
Table 28. Becton, Dickinson and Company (U.S.) SWOT Analysis
Table 29. Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Product and Services
Table 30. Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Cardinal Health, Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table 32. Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Major Business
Table 33. Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Total Revenue (USD Million) (2018-2019)
Table 34. Cardinal Health, Inc. (U.S.) SWOT Analysis
Table 35. Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product and Services
Table 36. Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Cook Group Incorporated (U.S.) Basic Information, Manufacturing Base and Competitors
Table 38. Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Major Business
Table 39. Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Total Revenue (USD Million) (2018-2019)
Table 40. Cook Group Incorporated (U.S.) SWOT Analysis
Table 41. Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Product and Services
Table 42. Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. FUJIFILM Holdings Corporation (Japan) Basic Information, Manufacturing Base and Competitors
Table 44. FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Major Business
Table 45. FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Total Revenue (USD Million) (2018-2019)
Table 46. FUJIFILM Holdings Corporation (Japan) SWOT Analysis
Table 47. FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Product and Services
Table 48. FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. B. Braun Melsungen AG (Germany) Basic Information, Manufacturing Base and Competitors
Table 50. B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Major Business
Table 51. B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Total Revenue (USD Million) (2018-2019)
Table 52. B. Braun Melsungen AG (Germany) SWOT Analysis
Table 53. B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Product and Services
Table 54. B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Argon Medical Devices (U.S.) Basic Information, Manufacturing Base and Competitors
Table 56. Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Major Business
Table 57. Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Total Revenue (USD Million) (2018-2019)
Table 58. Argon Medical Devices (U.S.) SWOT Analysis
Table 59. Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Product and Services
Table 60. Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Boston Scientific Corporation (U.S.) Basic Information, Manufacturing Base and Competitors
Table 62. Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Major Business
Table 63. Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Total Revenue (USD Million) (2018-2019)
Table 64. Boston Scientific Corporation (U.S.) SWOT Analysis
Table 65. Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Product and Services
Table 66. Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. INRAD, Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table 68. INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Major Business
Table 69. INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Total Revenue (USD Million) (2018-2019)
Table 70. INRAD, Inc. (U.S.) SWOT Analysis
Table 71. INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product and Services
Table 72. INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Medtronic plc (Ireland) Basic Information, Manufacturing Base and Competitors
Table 74. Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Major Business
Table 75. Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Total Revenue (USD Million) (2018-2019)
Table 76. Medtronic plc (Ireland) SWOT Analysis
Table 77. Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Product and Services
Table 78. Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Global Stereotactic-guided Biopsy Instrument Sales by Manufacturer (2018-2019) (K Units)
Table 80. Global Stereotactic-guided Biopsy Instrument Revenue by Manufacturer (2018-2019) (USD Million)
Table 81. Global Stereotactic-guided Biopsy Instrument Sales by Regions (2015-2020) (K Units)
Table 82. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Regions (2015-2020)
Table 83. Global Stereotactic-guided Biopsy Instrument Revenue by Regions (2015-2020) (USD Million)
Table 84. North America Stereotactic-guided Biopsy Instrument Sales by Countries (2015-2020) (K Units)
Table 85. North America Stereotactic-guided Biopsy Instrument Sales Market Share by Countries (2015-2020)
Table 86. North America Stereotactic-guided Biopsy Instrument Revenue by Countries (2015-2020) (USD Million)
Table 87. North America Stereotactic-guided Biopsy Instrument Revenue Market Share by Countries (2015-2020)
Table 88. Europe Stereotactic-guided Biopsy Instrument Sales by Countries (2015-2020) (K Units)
Table 89. Europe Stereotactic-guided Biopsy Instrument Sales Market Share by Countries (2015-2020)
Table 90. Europe Stereotactic-guided Biopsy Instrument Revenue by Countries (2015-2020) (USD Million)
Table 91. Asia-Pacific Stereotactic-guided Biopsy Instrument Sales by Regions (2015-2020) (K Units)
Table 92. Asia-Pacific Stereotactic-guided Biopsy Instrument Sales Market Share by Regions (2015-2020)
Table 93. Asia-Pacific Stereotactic-guided Biopsy Instrument Revenue by Regions (2015-2020) (USD Million)
Table 94. South America Stereotactic-guided Biopsy Instrument Sales by Countries (2015-2020) (K Units)
Table 95. South America Stereotactic-guided Biopsy Instrument Sales Market Share by Countries (2015-2020)
Table 96. South America Stereotactic-guided Biopsy Instrument Revenue by Countries (2015-2020) (USD Million)
Table 97. South America Stereotactic-guided Biopsy Instrument Revenue Market Share by Countries (2015-2020)
Table 98. Middle East & Africa Stereotactic-guided Biopsy Instrument Sales by Countries (2015-2020) (K Units)
Table 99. Middle East & Africa Stereotactic-guided Biopsy Instrument Sales Market Share by Countries (2015-2020)
Table 100. Middle East & Africa Stereotactic-guided Biopsy Instrument Revenue by Countries (2015-2020) (USD Million)
Table 101. Middle East & Africa Stereotactic-guided Biopsy Instrument Revenue Market Share by Countries (2015-2020)
Table 102. Global Stereotactic-guided Biopsy Instrument Sales by Type (2015-2020) (K Units)
Table 103. Global Stereotactic-guided Biopsy Instrument Sales Share by Type (2015-2020)
Table 104. Global Stereotactic-guided Biopsy Instrument Revenue by Type (2015-2020) (USD Million)
Table 105. Global Stereotactic-guided Biopsy Instrument Revenue Share by Type (2015-2020)
Table 106. Global Stereotactic-guided Biopsy Instrument Sales by Application (2015-2020) (K Units)
Table 107. Global Stereotactic-guided Biopsy Instrument Sales Share by Application (2015-2020)
Table 108. Global Stereotactic-guided Biopsy Instrument Sales Forecast by Regions (2021-2025) (K Units)
Table 109. Global Stereotactic-guided Biopsy Instrument Market Share Forecast by Regions (2021-2025)
Table 110. Global Stereotactic-guided Biopsy Instrument Sales Forecast by Type (2021-2025) (K Units)
Table 111. Global Stereotactic-guided Biopsy Instrument Market Share Forecast by Type (2021-2025)
Table 112. Global Stereotactic-guided Biopsy Instrument Sales Forecast by Application (2021-2025)
Table 113. Global Stereotactic-guided Biopsy Instrument Market Share Forecast by Application (2021-2025)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Stereotactic-guided Biopsy Instrument Picture
Figure 2. Global Sales Market Share of Stereotactic-guided Biopsy Instrument by Type in 2019
Figure 3. Needle-based Biopsy Instruments Picture
Figure 4. Localization Wires Picture
Figure 5. Procedure Trays Picture
Figure 6. Others Picture
Figure 7. Stereotactic-guided Biopsy Instrument Sales Market Share by Application in 2018
Figure 8. Breast Biopsy Picture
Figure 9. Lung Biopsy Picture
Figure 10. Colorectal Biopsy Picture
Figure 11. Prostate Biopsy Picture
Figure 12. Others Picture
Figure 13. Global Stereotactic-guided Biopsy Instrument Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Stereotactic-guided Biopsy Instrument Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Stereotactic-guided Biopsy Instrument Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Stereotactic-guided Biopsy Instrument Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Stereotactic-guided Biopsy Instrument Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Stereotactic-guided Biopsy Instrument Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Stereotactic-guided Biopsy Instrument Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Stereotactic-guided Biopsy Instrument Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Stereotactic-guided Biopsy Instrument Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Stereotactic-guided Biopsy Instrument Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Stereotactic-guided Biopsy Instrument Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Stereotactic-guided Biopsy Instrument Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Stereotactic-guided Biopsy Instrument Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Stereotactic-guided Biopsy Instrument Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Stereotactic-guided Biopsy Instrument Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Stereotactic-guided Biopsy Instrument Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Stereotactic-guided Biopsy Instrument Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Stereotactic-guided Biopsy Instrument Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Stereotactic-guided Biopsy Instrument Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Stereotactic-guided Biopsy Instrument Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Manufacturer in 2019
Figure 34. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Stereotactic-guided Biopsy Instrument Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Stereotactic-guided Biopsy Instrument Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020) (K Units)
Figure 39. Global Stereotactic-guided Biopsy Instrument Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Regions (2015-2020)
Figure 41. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Regions in 2018
Figure 42. North America Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
Figure 43. Europe Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
Figure 45. South America Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020)
Figure 47. North America Stereotactic-guided Biopsy Instrument Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Stereotactic-guided Biopsy Instrument Sales Market Share by Countries (2015-2020)
Figure 49. North America Stereotactic-guided Biopsy Instrument Sales Market Share by Countries in 2018
Figure 50. North America Stereotactic-guided Biopsy Instrument Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Stereotactic-guided Biopsy Instrument Revenue Market Share by Countries in 2018
Figure 52. United States Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Canada Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Mexico Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Europe Stereotactic-guided Biopsy Instrument Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Stereotactic-guided Biopsy Instrument Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Stereotactic-guided Biopsy Instrument Revenue Market Share by Countries in 2019
Figure 58. Germany Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020) (K Units)
Figure 59. UK Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020) (K Units)
Figure 60. France Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Russia Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Italy Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Asia-Pacific Stereotactic-guided Biopsy Instrument Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Stereotactic-guided Biopsy Instrument Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Stereotactic-guided Biopsy Instrument Revenue Market Share by Regions 2019
Figure 66. China Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Japan Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Korea Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020) (K Units)
Figure 69. India Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Southeast Asia Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020) (K Units)
Figure 71. South America Stereotactic-guided Biopsy Instrument Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Stereotactic-guided Biopsy Instrument Sales Market Share by Countries in 2019
Figure 73. South America Stereotactic-guided Biopsy Instrument Revenue Market Share by Countries in 2019
Figure 74. Brazil Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Argentina Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Middle East and Africa Stereotactic-guided Biopsy Instrument Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Stereotactic-guided Biopsy Instrument Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Stereotactic-guided Biopsy Instrument Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Stereotactic-guided Biopsy Instrument Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Egypt Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Turkey Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020) (K Units)
Figure 83. South Africa Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Global Stereotactic-guided Biopsy Instrument Sales and Growth Rate (2021-2025) (K Units)
Figure 85. Global Stereotactic-guided Biopsy Instrument Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Stereotactic-guided Biopsy Instrument Market Forecast (2021-2025) (K Units)
Figure 87. Europe Sales Stereotactic-guided Biopsy Instrument Market Forecast (2021-2025) (K Units)
Figure 88. Asia-Pacific Sales Stereotactic-guided Biopsy Instrument Market Forecast (2021-2025) (K Units)
Figure 89. South America Sales Stereotactic-guided Biopsy Instrument Market Forecast (2021-2025) (K Units)
Figure 90. Middle East & Africa Sales Stereotactic-guided Biopsy Instrument Market Forecast (2021-2025) (K Units)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel